ArticleEuropean journal of clinical pharmacology2004
Patterns of antihypertensive drug utilization in primary care.
Article in European journal of clinical pharmacology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 1 synthesis or guideline pooled it, 83 citations in OpenAlex.
- Cardiovascular medication utilization and adherence among adults living in rural and urban areas: a systematic review and meta-analysis.BMC public health · 2014Pooled it
- Impact of losartan on stroke risk in hypertensive patients in primary care.Clinical drug investigation · 2007Trial
- Article
- Associations of metabolic disorder factors with the risk of uncontrolled hypertension: a follow-up cohort in rural China.Scientific reports · 2017Article
- Barriers to lifestyle risk factor assessment and management in hypertension: a qualitative study of Australian general practitioners.Journal of human hypertension · 2013Article
- Managing hypertension among nursing-home residents and community-dwelling elderly in Germany: a comparative pharmacoepidemiological study.European journal of clinical pharmacology · 2012Article
- Article
- Treatment patterns and risk factor control in patients with and without metabolic syndrome in cardiac rehabilitation.Vascular health and risk management · 2012Article
- Prescribing pattern of antihypertensive drugs in a general hospital in central China.International journal of clinical pharmacy · 2011Article
- Current state of cardiac rehabilitation in Germany: patient characteristics, risk factor management and control status, by education level.Vascular health and risk management · 2011Article
- A global perspective on blood pressure treatment and control in a referred cohort of hypertensive patients.Journal of clinical hypertension (Greenwich, Conn.) · 2010Article
- [Current status of antihypertensive drug treatment in primary care practice at launch of the new renin inhibitor aliskiren (RASANT)].Medizinische Klinik (Munich, Germany : 1983) · 2010Article
- Evaluation of prescribing patterns in a German network of CAM physicians for the treatment of patients with hypertension: a prospective observational study.BMC family practice · 2009Article
- [Antihypertensive pharmacotherapy of patients in primary care with either a statutory or private health insurance].Medizinische Klinik (Munich, Germany : 1983) · 2009Article
- Management of hypertension with fixed dose combinations of candesartan cilexetil and hydrochlorothiazide: patient perspectives and clinical utility.Vascular health and risk management · 2009Review
- Stroke risk screening of adults with hypertension: prospective cross-sectional study in primary care.Clinical drug investigation · 2008Review
- Persistence with antihypertensive treatments: results of a 3-year follow-up cohort study.European journal of clinical pharmacology · 2007Article
- Prescribing pattern of antihypertensive drugs in primary care units in Turkey: results from the TURKSAHA study.European journal of clinical pharmacology · 2007Article
- Cardiovascular risk in obese hypertensive patients taking various antihypertensive drugs.Clinical drug investigation · 2007Article
- Management of high-risk patients with hypertension and left ventricular hypertrophy in Germany: differences between cardiac specialists in the inpatient and outpatient setting.BMC public health · 2006Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 5 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIn the treatment of hypertension, physicians' attitudes and practice patterns are receiving increased attention as contributors to poor blood pressure (BP) control. Thus, current use of antihypertensive drugs in primary care was analyzed and the association with selected physician and patient characteristics was assessed.
methodsThe Hypertension and Diabetes Risk Screening and Awareness (HYDRA) study is a cross-sectional point prevalence study of 45,125 primary care attendees recruited from a representative nationwide sample of 1912 primary care practices in Germany. Prescription frequencies of the various antihypertensive drugs in the individual patients were recorded by the physicians using standardized questionnaires. We assessed the association of patient variables [age, gender; co-morbidities such as diabetes, nephropathy or coronary heart disease (CHD)] and physician variables (general practitioner vs internist, guideline adherence, etc.) with drug treatment intensity and prescription patterns.
resultsOf all 43,549 patients for whom a physician diagnosis on hypertension or diabetes was available, 17,485 (40.1%) had hypertension. Of these hypertensive patients, 1647 (9.4%) received no treatment at all, 1191 (6.8%) received non-pharmacological measures only, and 14,647 (83.8%) were given one or more antihypertensive drugs. Drug treatment rates were lower in young patients (16-40 years: 57.4%). BP control was poor: 70.6% of all patients were not normalized, i.e., had BP >/=140/90 mmHg. Antihypertensive treatment was generally intensified with increasing age, or if complications or comorbidities were present. The use of the different drug classes was rather uniform across the various patient subgroups (e.g., by age and gender). Individualized treatment with regard to co-morbidities as recommended in guidelines was not the rule. Adherence to guidelines as self-reported by physicians as well as other physician characteristics (region, training etc.) did not result in more differentiated prescription pattern.
conclusionsDespite the broad armamentarium of drug treatment options, physicians in primary care did not treat hypertension aggressively enough. Treatment was only intensified at a late stage, after complications had occurred. Treatment should be more differentiated in terms of coexisting morbidities such as diabetes, nephropathy, or CHD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.